Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+217.0%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+217.0%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
31.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$30.37M-42.9%
2024$53.16M+528.0%
2023$8.46M+788.1%
2022$953083.00-79.4%
2021$4.62M-